Upload
dokiet
View
215
Download
0
Embed Size (px)
Citation preview
1
(Relates to Chapter 29, “Nursing Management: Obstructive Pulmonary Diseases,” in the textbook)
Focus on Asthma
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Asthma – DefinitionChronic inflammatory disorder of
airwaysCauses airway hyperresponsiveness
leading to wheezing, breathlessness, chest tightness, and cough
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 2
SignificanceAffects about 16 million AmericansWomen are 66% more likely to have
asthma than men.Older adults may be undiagnosed.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 3
2
Triggers of Asthma AllergensTriggers of Asthma Allergens
May be seasonal or year round depending on exposure to allergenHouse dust mitesCockroachesFurry animalsFungiMolds
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 4
Triggers of Asthma Exercise
Induced or exacerbated after exercisePronounced with exposure to cold airBreathing through a scarf or mask may ↓
likelihood of symptoms
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 5
Triggers of Asthma Air Pollutants
Can trigger asthma attacksCigarette or wood smokeVehicle exhaustElevated ozone levelsSulfur dioxide
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 6
3
Triggers of Asthma Occupational Factors
Most common form of occupational lung diseaseExposure to diverse agentsArrive at work well, but experience a
gradual decline
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 7
Triggers of Asthma Respiratory Infection
Major precipitating factor of an acute asthma attack ↑ inflammation hyperresponsiveness of
the tracheobronchial system
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 8
Triggers of AsthmaNose and Sinus Problems
Allergic rhinitis and nasal polypsLarge polyps are removed Sinus problems are usually related to
inflammation of the mucous membranes
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 9
4
Triggers of AsthmaDrugs and Food Additives
Asthma triad: Nasal polyps, asthma, and sensitivity to aspirin and NSAIDsWheezing develops in about 2 hours.Sensitivity to salicylates Found in many foods, beverages, and
flavoringsβ-Adrenergic blockers
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 10
Triggers of AsthmaDrugs and Food Additives
Food allergies may cause asthma symptoms.Rare in adultsAvoidance diets
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 11
Triggers of AsthmaGastroesophageal Reflux Disease
Exact mechanism is unknown.Reflux of acid could be aspirated into
lungs, causing bronchoconstriction.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 12
5
Triggers of AsthmaEmotional Stress
Psychologic factors can worsen the disease process.Attacks can trigger panic and anxiety.Extent of effect is unknown.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 13
Pathophysiology
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 14
Fig. 29-1. Pathophysiology of asthma. IL, Interleukin.
PathophysiologyPrimary response is chronic
inflammation from exposure to allergens or irritants. Leading to airway hyperresponsiveness
and acute airflow limitations
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 15
6
Pathophysiology Inflammatory mediators cause early-
phase response.Vascular congestionEdema formationProduction of thick, tenacious mucusBronchial muscle spasmThickening of airway walls
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 16
Early Phase Response of Asthma Triggered by Allergen
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 17
Factors Causing Obstruction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 18
7
PathophysiologyLate-phase responseOccurs within 4 to 10 hours after initial
attackOccurs in only 30% to 50% of patientsCan be more severe than early phase
and can last for 24 hours or longer
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 19
PathophysiologyLate-phase response If airway inflammation is not treated or
does not resolve, it may lead to irreversible lung damage.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 20
Clinical ManifestationsUnpredictable and variableRecurrent episodes of wheezing,
breathlessness, cough, and tight chestMay be abrupt or gradualLasts minutes to hours
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 21
8
Clinical ManifestationsExpiration may be prolonged. Inspiration-expiration ratio of 1:2 to 1:3
or 1:4Bronchospasm, edema, and mucus in
bronchioles narrow the airways.Air takes longer to move out.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 22
Clinical ManifestationsWheezing is unreliable to gauge
severity. Severe attacks may have no audible
wheezing.Usually begins upon exhalation
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 23
Clinical ManifestationsCough variant asthmaCough is only symptom.Bronchospasm is not severe enough to
cause airflow obstruction.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 24
9
Clinical ManifestationsDifficulty with air movement can
create a feeling of suffocation.Patient may feel increasingly anxious.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 25
Clinical ManifestationsAn acute attack usually reveals signs
of hypoxemia.Restlessness ↑ anxiety Inappropriate behavior
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 26
Clinical ManifestationsMore signs of hypoxemia ↑ pulse and blood pressurePulsus paradoxus (drop in systolic BP
during inspiratory cycle >10 mm Hg)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 27
10
Classification of AsthmaMild intermittentMild persistentModerate persistentSevere persistent
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 28
ComplicationsSevere acute attackRespiratory rate >30/min Pulse >120/minPEFR is 40% at best.Usually seen in ED or hospitalized
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 29
ComplicationsLife-threatening asthmaToo dyspneic to speakPerspiring profuselyDrowsy/confusedRequire hospital care and often
admitted to ICU
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 30
11
Diagnostic StudiesDetailed history and physical examPulmonary function testsPeak flow monitoringChest x-rayABGs
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 31
Diagnostic StudiesOximetryAllergy testingBlood levels of eosinophilsSputum culture and sensitivity
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 32
Collaborative CareEducationStart at time of diagnosis. Integrate through care.
Self-managementTailored to needs of patientCulturally sensitive
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 33
12
Collaborative CareDesired therapeutic outcomesControl or eliminate symptomsAttain normal lung functionRestore normal activitiesReduce or eliminate exacerbations and
side effects of medications
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 34
Drug Therapy
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 35
Fig. 29-4. Drug therapy: stepwise approach for managing asthma.
Asthma Control Test
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 36
Fig. 29-5.
13
Collaborative CareMild intermittent and mild persistent
asthmaAvoid triggers of acute attacks.Premedicate before exercising. Choice of drug therapy depends on
symptom severity.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 37
Collaborative CareAcute asthma episodeRespiratory distressTreatment depends upon severity and
response to therapy. Severity measured with flow rates
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 38
Collaborative CareAcute asthma episodeO2 therapy may be started and
monitored with pulse oximetry or ABGs in severe cases.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 39
14
Collaborative CareSevere exacerbationsMost therapeutic measures are the
same as for acute episode. ↑ in frequency and dose of bronchodilators
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 40
Collaborative CareSevere exacerbations IV corticosteroids are administered
every 4 to 6 hours, then are given orally.Continuous monitoring of patient is
critical. IV magnesium sulfate is given as a
bronchodilator.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 41
Collaborative CareSevere exacerbationsSupplemental O2 is given by mask or
nasal cannula for 90% O2 saturation.Arterial catheter may be used to facilitate
frequent ABG monitoring. IV fluids are given because of insensible
loss of fluids.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 42
15
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 43
The nurse anticipates intubation and mechanical ventilation for the patient with a severe exacerbation of asthma (status asthmaticus) when:
1. The PaCO2 is 60 mm Hg.2. The PaO2 decreases to 70 mm Hg.3. Severe respiratory muscle fatigue occurs.4. The patient has extreme anxiety and fear of
suffocation.
Audience Response Question
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 44
Drug TherapyLong-term control medicationsAchieve and maintain control of
persistent asthmaQuick-relief medicationsTreat symptoms of exacerbations
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 45
16
Drug TherapyThree types of antiinflammatory
drugsCorticosteroidsLeukotriene modifiersMonoclonal antibody to IgE
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 46
Drug TherapyCorticosteroids (e.g.,
beclomethasone, budesonide)Suppress inflammatory response Inhaled form is used in long-term
control.Systemic form to control exacerbations
and manage persistent asthma
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 47
Drug TherapyCorticosteroidsReduce bronchial hyperresponsivenessDecrease mucous productionAre taken on a fixed schedule
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 48
17
Drug TherapyCorticosteroidsOropharyngeal candidiasis, hoarseness,
and a dry cough are local side effects of inhaled drug. Can be reduced using a spacer or by gargling
after each use
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 49
Spacer
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 50
Fig. 29-6. Example of an AeroChamber spacer used with a metered-dose inhaler.
Drug TherapyLeukotriene modifiers or inhibitors
(e.g., zafirlukast, montelukast, zileuton)Block action of leukotrienes—potent
bronchoconstrictors
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 51
18
Drug TherapyLeukotriene modifiers or inhibitors Have both bronchodilator and
antiinflammatory effects Not indicated for acute attacksUsed for prophylactic and maintenance
therapy
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 52
Drug TherapyAnti-IgE (e.g., Xolair) ↓ circulating free IgE levelsPrevents IgE from attaching to mast
cells, preventing release of chemical mediatorsSubcutaneous administration every 2 to
4 weeks
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 53
Drug TherapyThree types of bronchodilatorsβ2-Adrenergic agonists MethylxanthinesAnticholinergics
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 54
19
Drug Therapyβ-Adrenergic agonists (e.g.,
albuterol, metaproterenol)Effective for relieving acute
bronchospasmOnset of action in minutes and duration
of 4 to 8 hours
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 55
Drug Therapyβ-Adrenergic agonists Prevent release of inflammatory
mediators from mast cellsNot for long-term use
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 56
Drug TherapyMethylxanthines (e.g., theophylline)Less effective long-term bronchodilatorAlleviates early phase of attacks but has
little effect on bronchial hyperresponsivenessNarrow margin of safety
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 57
20
Drug TherapyAnticholinergic drugs (e.g.,
ipratropium)Block action of acetylcholineUsually used in combination with a
bronchodilatorMost common side effect is dry mouth.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 58
Patient Teaching Related to Drug Therapy
Correct administration of drugs is a major factor in success. Inhalation of drugs is preferable to
avoid systemic side effects.MDIs, DPIs, and nebulizers are devices used
to inhale medications.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 59
Patient Teaching Related to Drug Therapy
Correct administration of drugs Using an MDI with a spacer is easier and
improves inhalation of the drug. DPI (dry powder inhaler) requires less
manual dexterity and coordination.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 60
21
Example of DPI
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 61
Fig. 29-8. Example of a dry powder inhaler (DPI).
Nebulizer
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Nonprescription Combination Drugs
Should be avoided in generalEpinephrine can also increase heart rate
and blood pressure.Ephedrine stimulates CNS and
cardiovascular system.Dietary supplements were banned in 2004.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 63
22
Nursing ManagementNursing Assessment
Health history Especially of precipitating factors and
medicationsABGsLung function tests
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 64
Nursing ManagementNursing Assessment
Physical examinationUse of accessory musclesDiaphoresisCyanosisLung sounds
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 65
Nursing ManagementNursing Diagnoses
Ineffective airway clearanceAnxietyDeficient knowledge
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 66
23
Nursing ManagementPlanning
Overall GoalsMaintain greater than 80% of personal
best PEFRHave minimal symptomsMaintain acceptable activity levels
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 67
Nursing ManagementPlanning
Overall GoalsFew or no adverse effectsNo recurrent exacerbations of asthma
or decreased incidence of asthma attacksAdequate knowledge to participate in
and carry out management
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 68
Nursing ManagementHealth Promotion
Teach patient to identify and avoid known triggers.Use dust coversUse scarves or masks for cold airAvoid aspirin or NSAIDs
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 69
24
Nursing ManagementHealth Promotion
Prompt diagnosis and treatment of upper respiratory infections and sinusitis may prevent exacerbation.
Fluid intake of 2 to 3 L every day
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 70
Nursing ManagementNursing Implementation
Acute interventionMonitor respiratory and cardiovascular
systems: Lung soundsRespiratory rate PulseBP
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 71
Nursing ManagementNursing Implementation
An important goal of nursing is to ↓the patient’s sense of panic. Stay with patient.Encourage slow breathingPosition comfortably.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 72
25
Nursing ManagementNursing Implementation
Ambulatory and home careMust learn about medications and
develop self-management strategiesPatient and health care professional
must monitor responsiveness to medication.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 73
Nursing ManagementNursing Implementation
Ambulatory and home care Patient must understand importance of
continuing medication when symptoms are not present.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 74
Nursing ManagementNursing Implementation
Important patient teachingSeek medical attention for
bronchospasm or when severe side effects occur.Maintain good nutrition.Exercise within limits of tolerance.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 75
26
Nursing ManagementNursing Implementation
Important patient teachingMeasure peak flow at least daily.Asthmatic individuals frequently do not
perceive changes in their breathing.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 76
Nursing ManagementNursing Implementation
Peak flow should be monitored daily and a written action plan should be followed according to results of daily PEFR.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 77
Nursing ManagementNursing Implementation
Peak flow resultsGreen ZoneUsually 80% to 100% of personal bestRemain on medications.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 78
27
Nursing ManagementNursing Implementation
Peak flow resultsYellow ZoneUsually 50% to 80% of personal best Indicates caution Something is triggering asthma.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 79
Nursing ManagementNursing Implementation
Peak flow results Red Zone 50% or less of personal best Indicates serious problemDefinitive action must be taken with health
care provider.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 80